Anthony Bergmann

Track

Insider profile

Currently holds a position at Capricor Therapeutics Inc

Positions

Position Company Period
Chief Financial Officer, Principal Accounting Officer Capricor Therapeutics Inc Jan. 1, 2018 -
Principal Accounting Officer, Vice President - Finance Capricor Therapeutics Inc Feb. 22, 2016 - Jan. 1, 2018
Principal Financial Officer and Vice President of Finance Capricor Therapeutics Inc Jan. 1, 2014 - Feb. 22, 2016
Director - Finance, Treasurer Capricor Therapeutics Inc Nov. 22, 2013 - Jan. 1, 2014
Anthony Bergmann's trades of Capricor Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-29 2026-06-25
PlS Planned sale
27,893 -25.6%
173.46
US$4,794,152 		27,893 -25.6% 173.46 US$4,794,152
2026-06-24 2026-06-24
PlS Planned sale
7,559 +30.2%
429.01
US$4,531,601 		7,559 +30.2% 429.01 US$4,531,601
2026-06-24 2026-06-22
PlS Planned sale
5,253 +31.4%
229.65
US$3,196,794 		5,253 +31.4% 229.65 US$3,196,794
2026-05-04 2026-05-01
PlS Planned sale
25,000 -75.2%
31.70
US$792,540 		25,000 -75.2% 31.70 US$792,540
2026-05-04 2026-05-01
PlS Planned sale
25,000 -75.2%
31.70
US$792,540 		25,000 -75.2% 31.70 US$792,540
2026-04-01 2026-03-31
PlS Planned sale
25,000 -75.2%
30.13
US$753,152 		25,000 -75.2% 30.13 US$753,152
2026-03-31 2026-03-31
PrS Proposed sale
75,000
27.77
US$2,082,750 		75,000 27.77 US$2,082,750